UK Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

UK Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The key factors propelling the growth of the market there are huge investments made by the private players in neurology devices, increase in R&D in the field of neurotherapies, and rising of the aging population.

The growth of the neurology devices market in UK is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.

In addition, with the increasing healthcare spending, increasing investment by medical device manufactures, and increasing neurological disease prevalence are expected to drive the overall Neurology Devices market growth in UK.

Key Market TrendsNeurostimulation Devices is expected to Dominate the UK Neurology Devices Market

Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific part of the patient’s brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson’s disease. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population.

In addition, as the geriatric population is rising, there are increasing incidences of neurological disorders that are expected to rise in the coming years. Hence the demand for these devices will increase in the future.

Competitive Landscape

United Kingdom is a developed region with well-structured healthcare system. As a result, many global players in the neurology devices market are present in the country. Moreover, some domestic players have also been competing in the UK market. These factors have made the region very competitive.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corporation
Johnson and Johnson
Medtronic PLC
MicroPort Scientific Corporation
Nihon Kohden Corporation
Penumbra Inc.
Smith & Nephew
Stryker Corporation

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.